Degron Therapeutics vs STORM Therapeutics
Degron Therapeutics vs STORM Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Degron Therapeutics is on 62/100 and STORM Therapeutics on 51/100.
Where each one leads
Degron Therapeutics
- our overall score: 62/100 against 51/100
STORM Therapeutics
- agent readiness: 34/100 against 27/100
- domain rating: 28/100 against 25/100
- funding raised: $57.6M against $40.0M
At a glance
| Measure | Degron Therapeutics | STORM Therapeutics |
|---|---|---|
| What it is | Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines. | Clinical-stage biotech company targeting RNA modifications for novel cancer therapies. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Healthcare | Biotechnology, Pharmaceuticals, Oncology, RNA Therapeutics |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2020 | 2015 |
| Headquarters | San Diego, USA | Cambridge, United Kingdom |
| Status | Active | Active |
Size, funding and growth
| Measure | Degron Therapeutics | STORM Therapeutics |
|---|---|---|
| Employees | 24 | Not published |
| Total funding | $40.0M | $57.6M |
| Latest round | Series A Extension | Seed |
| Valuation | $1.1B | Not published |
| LinkedIn followers | 1,380 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Degron Therapeutics | STORM Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 51/100 |
| Traction | Not published | 39/100 |
| Team | 24/100 | 30/100 |
| Search visibility | 57/100 | 13/100 |
| Quality | Not published | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (27/100) | F (34/100) |
| Domain ratingLink authority, 0-100 | 25/100 | 28/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Degron Therapeutics | STORM Therapeutics |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| Analytics | Not detected | Google Analytics 4 |
Degron Therapeutics vs STORM Therapeutics: common questions
Which is better, Degron Therapeutics or STORM Therapeutics?
On our 0-100 score Degron Therapeutics rates higher (62/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do Degron Therapeutics and STORM Therapeutics compare on the numbers?
Degron Therapeutics leads on our overall score (62/100 against 51/100). STORM Therapeutics leads on agent readiness (34/100 against 27/100), domain rating (28/100 against 25/100), funding raised ($57.6M against $40.0M).
Read the full Degron Therapeutics review and pricing or the STORM Therapeutics review and pricing. You can also browse other Degron Therapeutics alternatives we track.